Amlodipine News and Research

RSS
Boehringer Ingelheim Pharmaceuticals receives NDA approval from FDA for its Micardis Tablets 80 mg

Boehringer Ingelheim Pharmaceuticals receives NDA approval from FDA for its Micardis Tablets 80 mg

Modest decline for hypertension drug industry over the next decade

Modest decline for hypertension drug industry over the next decade

Diuretic drug works best at reducing risk of heart failure in hypertension

Diuretic drug works best at reducing risk of heart failure in hypertension

ACE inhibitor calcium channel blocker combo drug shown to reduces heart attacks

ACE inhibitor calcium channel blocker combo drug shown to reduces heart attacks

Diuretic reduces risk for type of heart failure that affects women more often than

Diuretic reduces risk for type of heart failure that affects women more often than

Ranbaxy and Pfizer settle on Lipitor patent litigation

Ranbaxy and Pfizer settle on Lipitor patent litigation

Mylan confirms Azor patent challenge

Mylan confirms Azor patent challenge

Two drug combo blood pressure therapy lowers cardiovascular risk

Two drug combo blood pressure therapy lowers cardiovascular risk

Evidence strongly supports diuretics as initial metabolic syndrome therapy, especially in black patients

Evidence strongly supports diuretics as initial metabolic syndrome therapy, especially in black patients

Gene variations associated with effectiveness of blood pressure medications

Gene variations associated with effectiveness of blood pressure medications

FDA to review potential anti-arrhythmic claims for Ranexa

FDA to review potential anti-arrhythmic claims for Ranexa

Caraco Pharmaceutical Labs announces FDA approval to market generic Norvasc

Caraco Pharmaceutical Labs announces FDA approval to market generic Norvasc

Lupin receives approval for Amlodipine tablets

Lupin receives approval for Amlodipine tablets

Ranbaxy receives approval to manufacture and market Amlodipine Besylate tablets

Ranbaxy receives approval to manufacture and market Amlodipine Besylate tablets

Roxane Laboratories announces launch of Amlodipine Besylate tablets

Roxane Laboratories announces launch of Amlodipine Besylate tablets

Ranbaxy receives tentative approval to manufacture Amlodipine Besylate tablets

Ranbaxy receives tentative approval to manufacture Amlodipine Besylate tablets

Combination of medicines best for blood pressure control

Combination of medicines best for blood pressure control

Single-tablet combination of atorvastatin and amlodipine for high blood pressure effective

Single-tablet combination of atorvastatin and amlodipine for high blood pressure effective

FDA confirms Mylan's status as only approved ANDA for all strengths of Amlodipine Besylate tablets

FDA confirms Mylan's status as only approved ANDA for all strengths of Amlodipine Besylate tablets

U.S. District Court grants Mylan extension for consideration of Amlodipine Besylate exclusivity

U.S. District Court grants Mylan extension for consideration of Amlodipine Besylate exclusivity